Advanced BioScience Laboratories, Inc (ABL) is an Institut Mérieux company ABL is a contract development and manufacturing organization (CDMO) specialized in developing and manufacturing viruses for vaccine candidates, gene, and cancer therapies. ABL’s mission is to provide GMP viral vectors from early-stage clinical studies to commercialization, contributing to the success of its clients’ immunotherapeutic innovations. ABL’s CDMO services include bulk drug substance, fill/finish of drug product, process and assay development, and bioanalytical testing. ABL is a subsidiary of the Institut Mérieux and operates from various locations in Europe and the US. www.abl-biomanufacturing.com.

ABL is also a contract research organization and leading global provider of immunology and biomarker analyses, offering expert laboratory & sample management services to advance promising candidates from discovery to the clinic. www.ablinc.com